Lifeaz SAS

Based in France, Lifeaz SAS specializes in the development of advanced defibrillation devices to enhance cardiac emergency response, providing innovative solutions for public and private use. Lifeaz SAS, founded in 2015, is headquartered in Paris, France. The company develops automated external defibrillators (AEDs) aimed at improving emergency response to cardiac events. The founder's background details are not specified, and there are no records of significant pivoting or subsidiaries.

Lifeaz specializes in the development and distribution of advanced defibrillation devices aimed at enhancing cardiac emergency response. Its core product offering includes portable automated external defibrillators (AEDs) designed for both public and private use, which facilitate rapid defibrillation in cases of sudden cardiac arrest. These devices are engineered to be user-friendly, enabling individuals with no medical background to deliver life-saving shocks to victims. The target customer base includes businesses, educational institutions, and healthcare facilities, aiming to promote safety in environments where large groups gather.

Lifeaz has established a presence in several geographical markets, including Europe and North America, focusing on areas with high foot traffic such as malls, airports, and corporate offices. Lifeaz generates revenue primarily through direct sales of its AED devices and associated training programs. The transaction structure typically involves direct-to-consumer sales, where businesses and organizations purchase units in bulk to equip their facilities. Additionally, partnerships with health and safety organizations facilitate access to training and certification services, enhancing the value proposition of the AEDs.

Pricing structures for these products are tiered based on the volume purchased, with specific pricing plans available to cater to different client needs, including discounted rates for large orders. Flagship products include their patented Lifeaz AED, which is marketed as a key solution for improving emergency response times in critical situations. Lifeaz SAS plans to leverage its recent funding of EUR 13. 00 mn to support the launch of new product lines and expand its market presence.

The company is focusing on developing innovative AED devices with enhanced features, targeting to introduce these products within the next 12 to 18 months. Furthermore, Lifeaz aims to penetrate new markets in Europe and North America, specifically targeting high-density urban areas and large public venues by 2025. The involvement of XAnge as a new investor will also help bolster these initiatives. In February 2026, Lifeaz SAS raised EUR 13 million in venture funding from BNP Paribas, Go Capital, Mirova, XAnge and Investir&+.